威澳门尼斯人-www.2325cc|网站主页-欢迎您

威澳门尼斯人2325cc

EN

R & D RESULTS

At present, our company mainly focuses on the R & D , production and sales of APIs & chemical intermediates.Our main focus is on antiviral, antitumor, cardio-cerebrovascular and digestive drugs. We have velpatasvir, redipavir, peramivir, eribulin, erlotinib, pabuterib, and other new drug products. Several innovative developing drugs are under development.